Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache

Neuropsychiatric Disease and Treatment

Volumn 3, Issue 6, 2007, Pages 761-764

  Evers, Stefan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Botulinum toxin A; Chronic daily headache; Chronic migraine; Chronic tension type headache

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

CHRONIC DAILY HEADACHE; CHRONIC TENSION HEADACHE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED HEADACHE; HEADACHE; HEMICRANIA CONTINUA; HUMAN; LONG TERM CARE; NEW DAILY PERSISTENT HEADACHE; REVIEW; TRANSFORMED MIGRAINE;

EID: 38149006173     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Argoff CE. 2003. The use of botulinum toxins for chronic pain and headaches. Curr Treat Options Neurol, 5:483-92.
2. Blumenfeld AM, Dodick DW, Silberstein SD. 2004. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. Dermatol Clin, 22:167-75.
3. Burch CM, Kokoska MS, Glaser DA, et al. 2001. Treatment of frontal tension headaches with botulinum toxin A. Cephalalgia, 21:489.
4. Dodick DW 2003. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside. Headache, 43 (Suppl 1):25-33.
5. Dodick DW, Mauskop A, Elkind AH, et al. 2005. Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache, 45:315-24.
6. Elkind AH, Turkel CC. 2005. Botulinum toxin type A for the prophylaxis of headache in migraineurs with 16 days or more days of headache per 30 days: effect on frequency of all headache attacks and headaches of >4 hours in duration (randomised, double-blind, placebo-controlled study). J Neurol, 252:II/60.
7. Empl M, Ceballos-Baumann A, Tölle T, et al. 2005. Treatment of chronic tension-type headache with botulinum toxin A (Dysport®): a double-blind multicentre study. J Neurol, 252 (SuppI 2):II/61-II/ 62.
8. Evers S. 2004. Botulinum toxin and the management of chronic headaches. Curr Opin Otolaryngol Nead Neck Surg, 12:197-203.
9. Freitag FG, Diamond S, Diamond M, et al. 2006. Botulinum toxin type A (BnTxA) in the treatment of chronic migraine. Headache, 46:849.
10. Göbel H, Lindner V, Krack P, et al. 1999. Treatment of chronic tension-type headache with botulinum toxin. Cephalalgia, 19:455.
11. Headache Classification Committee of the International Headache Society. 1989. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia, 8 (Suppl 7):1-92.
12. Headache Classification Committee of the International Headache Society. 2004. International classification of headache disorders 2nd ed. Cephalalgia, 24 (Suppl 1): 1-160.
13. Jakubowski M, McAllister PJ, Bajwa ZH, et al. 2006. Exploding vs imploding headache in migraine prophylaxis with Botulinum Toxin A. Pain, 125:286-95.
14. Kokoska MS, Glaser DA, Burch CM, et al. 2004. Botulinum toxin injections for the treatment of frontal tension headache. J Headache Pain, 5:103-9.
15. Mathew NT, Kaup AO. 2002. The use of botulinum toxin type A in headache treatment. Curr Treat Options Neurol, 4:365-73.
16. Mathew NT, Frishberg BM, Gawel M, et al. 2005. Botulinum toxin type A (Botox®) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache, 45:293-307.
17. Ondo WG, Vuong KD, Derman HS. 2004. Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Cephalalgia, 24:60-5.
18. Padberg M, de Bruijn SFTM, de Haan RJ, et al. 2004. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia, 24:675-90.
19. Relja MA, Klepac N. 2001. Botulinum toxin A as prophylactic treatment in chronic tension-type headache: long-term follow-up study. Neurology, 56 (Suppl 3):A349-50.
20. Rollnik JD, Tanneberger O, Schubert M, et al. 2000. Treatment of tension-type headache with botulinum toxin A: a double-blind, placebo-controlled study. Headache, 40:300-5.
21. Schmitt WJ, Slowey E, Fravi N, et al. 2001. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache, 41:658-64.
22. Schoenen J. 1995. Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials. Cephalalgia, 15:165-79.
23. Schulte-Mattler W, Krack P, BoNTTH study group. 2004. Treatment of chronic tension-type headache with botalinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain, 109:110-4.
24. Silberstein SD, Lipton RB. 2000. Chronic daily headache. Curr Opin Neurol, 13:277-83.
25. Silberstein SD, Stark SR, Lucas SM, et al. 2005. Botulinum toxin type A for the prophylactic treatment of chronic daily hedache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc, 80: 1126-37.
26. Silberstein SD, Göbel H, Jensen R, et al. 2006. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multi-center, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia, 26:790-800.
27. Smuts JA, Baker MK, Smuts HM, et al. 1999. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol, 6 (Suppl 4):99-102.
28. Stovner LJ, Zwart JA, Hagen K, et al. 2006. Epidemiology of headache in Europe. Eur J Neurol, 13:333-45.
29. Tfelt-Hansen P, Block G, Dahlöf C, et al. 2000. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia, 20:765-86.